EpiBone, Inc. Secures Funding Round Led by Kendall Capital Partners to Accelerate Global Expansion of Clinical Trials
Press Releases
November 8, 2024

EpiBone, Inc. Secures Funding Round Led by Kendall Capital Partners to Accelerate Global Expansion of Clinical Trials

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- EpiBone, Inc., a leading regenerative medicine company at the forefront of skeletal repair, announces the successful close of a convertible note funding round

bradford

The Bradford Era

More by this Author
Local & Social